Valuation: Zynex, Inc.

Market Cap 3.83M 3.32M 3.1M 2.85M 5.39M 364M 5.44M 36.55M 14.29M 182M 14.38M 14.06M 603M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 33.01M 30.78M 28.28M 53.48M 3.62B 54.07M 363M 142M 1.81B 143M 140M 5.99B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-0.90%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.1
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap.
7/27/25 A Free

Chief Operating Officer

11,293 0.0355%
6/5/25 A Tax

Chief Financial Officer

8,982 0.0282%
5/15/25 A Free

Director

10,000 0.0314%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-95.65%-99.35% 1.69M
-1.62%+0.93%+21.97%+2.99% 212B
-1.38%-0.88%-1.17%-24.35% 139B
-1.90%+3.20%-23.77%+18.31% 133B
+1.36%+7.87%-53.43%-3.52% 70.19B
+0.88%+7.90%+12.95%+12.00% 51.14B
-0.28%+9.67%-16.00%-19.59% 50.09B
-0.43%+0.95%+22.64%+11.32% 39.48B
+5.69%+6.70%+36.43%+35.92% 36.79B
+2.45%+7.15%+114.46%+9.53% 29.92B
Average +1.00%+1.28%+1.84%-5.67% 76.13B
Weighted average by Cap. -0.45%+3.55%+4.09%+1.47%

Financials

2023 2024
Net sales 184M 160M 149M 137M 259M 17.53B 262M 1.76B 688M 8.76B 692M 677M 29.04B 192M 167M 156M 143M 271M 18.3B 274M 1.84B 718M 9.15B 722M 707M 30.31B
Net income 9.73M 8.45M 7.88M 7.24M 13.69M 926M 13.84M 92.89M 36.31M 463M 36.55M 35.75M 1.53B 2.99M 2.6M 2.42M 2.23M 4.21M 285M 4.26M 28.58M 11.17M 142M 11.24M 11M 472M
Net Debt 31.59M 27.43M 25.57M 23.49M 44.43M 3B 44.92M 302M 118M 1.5B 119M 116M 4.98B 34.19M 29.69M 27.68M 25.43M 48.09M 3.25B 48.62M 326M 128M 1.63B 128M 126M 5.39B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock